Troy Edward Wilson - 16 Jun 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role: Director
Signature: /s/ Troy Edward Wilson
Issuer symbol: PBYI
Transactions as of: 16 Jun 2022
Net transactions value: -$71,971
Form type: 4
Filing time: 21 Jun 2022, 19:12:17 UTC
Previous filing: 17 Jun 2022
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBYI	Common Stock	Sale	$71,971	-27,858	-50%	$2.58	27,350	16 Jun 2022	Direct	F1, F2
holding	PBYI	Common Stock						400	16 Jun 2022	By Child #1
holding	PBYI	Common Stock						150	16 Jun 2022	By Child #2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold pursuant to a Rule 10b5-1 trading plan.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.544 to $2.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

These shares were sold pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.544 to $2.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.